S&P GSCI PALLADIUM INDEX

Real-time USA  -  05/17 08:05:10 pm EDT
1302.17 PTS   +0.00%
02/24Centessa Pharmaceuticals Doses First Patient in Phase 3 Trial of Lixivaptan; Payment Triggered
MT
2021Centessa Initiates Phase 3 Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease
MT
 SummaryQuotesChartsNewsComponents 
Quotes 5-day view   Real-time Quote. Real-time Usa
05/11/2022 05/12/2022 05/13/2022 05/16/2022 05/17/2022 Date
1289.63(c) 1197.895(c) 1232.589(c) 1284.375(c) 1302.1684 Last
-1.60% -7.11% +2.90% +4.20% 0.00% Change
More quotes
All news about S&P GSCI PALLADIUM INDEX
02/24Centessa Pharmaceuticals Doses First Patient in Phase 3 Trial of Lixivaptan; Payment Tr..
MT
2021Centessa Initiates Phase 3 Study of Lixivaptan in Autosomal Dominant Polycystic Kidney ..
MT
More news
News in other languages on S&P GSCI PALLADIUM INDEX
04/25Rusas Rosatom y Nornickel planean un proyecto de litio, reporta RIA
04/25Producción de níquel de la rusa Nornickel sube en el primer trimestre, la de paladio ca..
04/19Los metales preciosos caen por la preocupación ante las sanciones -- Market Talk
04/07Oro sube por preocupaciones sobre inflación y Ucrania
03/30TESLA FIRMÓ ACUERDO SECRETO POR SUMI : reporte
More news
Chart S&P GSCI PALLADIUM INDEX
Duration : Period :
S&P GSCI Palladium Index Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends S&P GSCI PALLADIUM INDEX
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral